Recent analyst updates have led to a slight increase in Gilead Sciences’ fair value price target, moving from $127.23 to $129 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback